Corporate News 10-Jul-17
Gallantt Metal gets revision in credit ratings
From India Ratings and Research
Gallantt Metal announced that India Ratings and Research, A Fitch Group Company has affirmed the Company a Long Term Issuer Rating of 'IND-A'. The Outlook is stable.
Rating Actions on Credit Facilities are as under:
- Fund-based limits: Long Term 'IND A-' /Stable and Short Term 'IND A2+'
- non-fund-based limits: assigned Short-Term – 'IND A2+'.
Previous News
Board of Gallantt Ispat recommends final dividend
( Corporate News - 22-May-25 12:12 )
Gallantt Ispat consolidated net profit rises 21.93% in the March 2025 quarter
( Results - Announcements 22-May-25 07:39 )
Gallantt Ispat to declare Quarterly Results
( Corporate News - 16-May-25 14:46 )
Board of Gallantt Ispat approves capacity expansion and new captive solar plant
( Corporate News - 16-Apr-25 19:28 )
Gallantt Ispat rises after board approves Rs 1,014 crore capex plan
( Hot Pursuit - 16-Apr-25 14:20 )
Gallantt Ispat to conduct board meeting
( Corporate News - 12-Apr-25 09:20 )
Board of Gallantt Ispat to consider proposal for capacity expansion
( Corporate News - 11-Apr-25 15:28 )
Gallantt Ispat spurts as board to mull capacity expansion
( Hot Pursuit - 11-Apr-25 14:48 )
Gallantt Ispat cancels board meeting
( Corporate News - 09-Apr-25 10:29 )
Gallantt Ispat to conduct board meeting
( Corporate News - 04-Apr-25 09:30 )
Gallantt Ispat schedules board meeting
( Corporate News - 29-Jan-25 17:10 )
Other Stories
Board of HCL Technologies recommends Interim Dividend
14-Jul-25 17:52
Objectone Information Systems to conduct board meeting
14-Jul-25 17:50
JTEKT India AGM scheduled
14-Jul-25 17:50
Setco Automotive to discuss results
14-Jul-25 17:50
Saurashtra Cement to hold board meeting
14-Jul-25 17:49
John Cockerill India to table results
14-Jul-25 17:49
ATV Projects India to conduct board meeting
14-Jul-25 17:49
Shilchar Technologies schedules AGM
14-Jul-25 17:49
Sun Pharma settles litigation related to LEQSELVI™ with Incyte
14-Jul-25 16:53
Sun Pharmaceutical Industries launches LEQSELVI™ (deuruxolitinib) 8 mg tablets in United States
14-Jul-25 16:48
Back
Top
